Study on Ceftazidime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
Status:
Suspended
Trial end date:
2022-12-15
Target enrollment:
Participant gender:
Summary
In the proposed study, the investigators plan to evaluate the efficacy and safety of
Ceftazidime Sodium and Sulbactam Sodium for Injection(2:1) for the treatment of respiratory
and urinary tract acute bacterial infection.